Product Information
DARIFENACIN ER 7.5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.5762 per EA under NDC 69097043105. Its NADAC has been published 509 times since Nov 23, 2016.
FDA first approved this application on Sep 1, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097043105
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DARIFENACIN HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207664FDA Approved
9/1/2016
TE Code
AB
On Market Since
9/1/2016
Pharmacological Classes
Price Statistics
The NADAC for DARIFENACIN ER 7.5 MG TABLET has been published 509 times since Nov 23, 2016, and over the history we have for it it has declined 92.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5762 per EA |
|---|---|
| All-time high | $7.8449 (Dec 14, 2016) |
| All-time low | $0.5115 (Aug 20, 2025) |
| 52-week high | $0.7315 |
| 52-week low | $0.5115 |
| Median price | $1.8326 |
| Average price | $2.6405 |
| Largest weekly change | +76.3% (May 22, 2019) |
| Weeks tracked | 509 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DARIFENACIN ER 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 7.5 MG TABLET, manufactured by Cipla USA Inc., is $0.5762 per EA (NDC 69097043105), effective Aug 19, 2026.
How has the price of DARIFENACIN ER 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DARIFENACIN ER 7.5 MG TABLET has declined 92.7%. It has been tracked across 509 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 7.5 MG TABLET?
Since Nov 23, 2016, the NADAC for DARIFENACIN ER 7.5 MG TABLET has ranged from a low of $0.5115 (Aug 20, 2025) to a high of $7.8449 (Dec 14, 2016), with a median of $1.8326 per EA.
Are there cheaper alternatives to DARIFENACIN ER 7.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DARIFENACIN ER 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DARIFENACIN ER 7.5 MG TABLET?
DARIFENACIN ER 7.5 MG TABLET (NDC 69097043105) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.